Joseph S. Zakrzewski, Director at ACCELERON PHARMA INC (XLRN), sold 18,900 shares at $141.28 ($2.7M) on 2021-04-05, disclosed to the SEC on 2021-04-05.
Open-market sale of $2.7M XLRN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $140.31 | 6,748 | $947K | 35.6% |
| 2 | $140.31 | 6,748 | $947K | 35.6% |
| 3 | $141.28 | 2,152 | $304K | 11.4% |
| 4 | $141.28 | 2,152 | $304K | 11.4% |
| 5 | $142.27 | 1,100 | $156K | 5.9% |
| Total | $140.64 avg | 18,900 |
| $2.7M |
| 100% |
| Filing → |
| ANTX | SELL | 2024-01-19 | $1.9M | — | Filing → |
| CYT | BUY | 2022-12-08 | $28K | — | Filing → |
| CYT | BUY | 2022-05-16 | $1K | — | Filing → |